Background In May 2016, the U.S. Food and Drug Administration (FDA) released a Drug Safety Communication concerning the antipsychotic drugs, Abilify, Abilify Maintena, and Aristada. This safety announcement provided the following warning: The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, … [Read more...]